Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Marketable Securities: €0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:ERFO Laboratorio Farmaceutico Erfo SpA MIL:ERFO
70 GF Score
Price €1.18
GF Value €2.12
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Laboratorio Farmaceutico Erfo SpA Marketable Securities?

Laboratorio Farmaceutico Erfo SpA MIL:ERFO -1.67% 70 Marketable Securities is €0.00 Mil as of Dec. 2025. GuruFocus rates MIL:ERFO with a GF Score™ of 70/100 and a GF Value™ of €2.12 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Laboratorio Farmaceutico Erfo SpA's Marketable Securities for the quarter that ended in Dec. 2025 was €0.00 Mil.

Laboratorio Farmaceutico Erfo SpA  (MIL:ERFO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Laboratorio Farmaceutico Erfo SpA Marketable Securities Related Terms

Laboratorio Farmaceutico Erfo SpA Marketable Securities Historical Data

* Premium members only.

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorio Farmaceutico Erfo SpA Marketable Securities Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MIL:ERFO
70GF Score
Laboratorio Farmaceutico Erfo SpA MIL:ERFO
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorio Farmaceutico Erfo SpA Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.00 Mil mean?
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a Marketable Securities of €0.00 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors.
Is Laboratorio Farmaceutico Erfo SpA's Marketable Securities too high?
Laboratorio Farmaceutico Erfo SpA's current Marketable Securities is €0.00 Mil. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's Marketable Securities compare to KHC and GIS?
Laboratorio Farmaceutico Erfo SpA's Marketable Securities of €0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Consumer Packaged Goods company?
A good Marketable Securities depends on the Consumer Packaged Goods industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. Laboratorio Farmaceutico Erfo SpA's current Marketable Securities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.12, compared to a current price of €1.18 — trading 44.3% below its estimated fair value. The current Marketable Securities is €0.00 Mil. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current Marketable Securities is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued. The current stock price of €1.18 is trading 44.3% below its estimated GF Value™ of €2.12. GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.

Key valuation signals for MIL:ERFO:

  • Marketable Securities: €0.00 Mil
  • GF Value™: €2.12 vs. price of €1.18 (44.3% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laboratorio Farmaceutico Erfo SpA Business Description

Address Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
70GF Score

Get the complete analysis for MIL:ERFO

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.18
Price
€2.12
GF Value